España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Exelixis
EXEL
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$34.83
0.18
0.52%
At close: -
$35.02
0.19
0.55%
After Hours: 4:49 PM EDT
Get Report
Comment
Exelixis (EXEL) Forecast
News
Earnings
Exelixis (EXEL) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Exelixis (NASDAQ:EXEL) Stock
Exelixis Stock (NASDAQ: EXEL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Sunday, November 03, 2024
Reddit, Roblox And Garmin Are Among Top 10 Large Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?
Lekha Gupta
Wednesday, October 30, 2024
Guggenheim Maintains Buy on Exelixis, Raises ...
Benzinga Newsdesk
Stephens & Co. Maintains Equal-Weight on Exel...
Benzinga Newsdesk
Piper Sandler Maintains Overweight on Exelixi...
Benzinga Newsdesk
RBC Capital Reiterates Outperform on Exelixis...
Benzinga Newsdesk
Truist Securities Maintains Buy on Exelixis, ...
Benzinga Newsdesk
Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Wells Fargo Maintains Overweight on Exelixis,...
Benzinga Newsdesk
BMO Capital Maintains Outperform on Exelixis,...
Benzinga Newsdesk
Exelixis shares are trading higher after the ...
Benzinga Newsdesk
Tuesday, October 29, 2024
Exelixis Raises FY2024 Sales Guidance from $1...
Benzinga Newsdesk
Exelixis Q3 2024 Adj. EPS $0.47 Beats $0.35 E...
Benzinga Newsdesk
Monday, October 28, 2024
Earnings Preview: Exelixis
Benzinga Insights
Monday, October 21, 2024
Analyst Ratings For Exelixis
Benzinga Insights
Navigating 16 Analyst Ratings For Exelixis
Benzinga Insights
TD Cowen Maintains Buy on Exelixis, Raises Pr...
Benzinga Newsdesk
Wednesday, October 16, 2024
RBC Capital Maintains Outperform on Exelixis,...
Benzinga Newsdesk
Stifel Maintains Hold on Exelixis, Raises Pri...
Benzinga Newsdesk
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Tuesday, October 15, 2024
B of A Securities Maintains Buy on Exelixis, ...
Benzinga Newsdesk
Exelixis shares are trading higher after the ...
Benzinga Newsdesk
Exelixis Wins Patent Infringement Case Agains...
Benzinga Newsdesk
Watching Exelixis; Traders Circulate Exelixis...
Benzinga Newsdesk
'Merck Keeps Kinase Inhibitor Options Open As...
Benzinga Newsdesk
Exelixis Shares Resume Trade Following Circui...
Benzinga Newsdesk
Monday, October 14, 2024
Exelixis And Merck Sign Clinical Development ...
Benzinga Newsdesk
Friday, October 11, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Morgan Stanley Maintains Equal-Weight on Exel...
Benzinga Newsdesk
Monday, October 07, 2024
Exelixis Gains 20.7% in Three Months: Is This the Right Time to Buy?
Zacks
Friday, October 04, 2024
Key Takeaways From Exelixis Analyst Ratings
Benzinga Insights
RBC Capital Maintains Outperform on Exelixis,...
Benzinga Newsdesk
Thursday, September 26, 2024
RBC Capital Reiterates Outperform on Exelixis...
Benzinga Newsdesk
Friday, September 20, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Thursday, September 19, 2024
UBS Initiates Coverage On Exelixis with Neutr...
Benzinga Newsdesk
Wednesday, September 18, 2024
A Closer Look at 5 Analyst Recommendations For Exelixis
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Exelixi...
Benzinga Newsdesk
Monday, September 16, 2024
Exelixis Announces Final Results From Phase 3...
Benzinga Newsdesk
Reported Sunday, Exelixis Presents Final Phas...
Benzinga Newsdesk
Thursday, August 08, 2024
Expert Outlook: Exelixis Through The Eyes Of 5 Analysts
Benzinga Insights
Truist Securities Reiterates Buy on Exelixis,...
Benzinga Newsdesk
Wednesday, August 07, 2024
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Analyst Sees Exelixis At Inflection Point Despite Mixed Trial Results
Vandana Singh
RBC Capital Reiterates Outperform on Exelixis...
Benzinga Newsdesk
Exelixis shares are trading higher after the ...
Benzinga Newsdesk
US Stocks Set To Extend Gains Despite Mixed Earnings, VIX Dips Back Toward Pre-Sell-Off Levels: Analyst Says Pullback Is A 'Growth Scare' And Not 'Calamity'
Shanthi Rexaline
Tuesday, August 06, 2024
Exelixis Sees 2024 Total Revenues $1.975B-$2....
Benzinga Newsdesk
Exelixis shares are trading higher after the ...
Benzinga Newsdesk
Exelixis Q2 2024 Adj. EPS $0.84 Beats $0.30 E...
Benzinga Newsdesk
Wall Street Rebounds After Selloff, VIX Falls, Dollar Surges Against Yen: What's Driving Markets Tuesday?
Piero Cingari
Exelixis Announces U.S. FDA Accepted The Supp...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch